Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1688564A enables efficient taxane amide conversion. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel sulfonamide-based synthesis for high-purity quinolone intermediates. Safe, scalable process reducing hazardous reagents for reliable pharmaceutical supply chains.
Novel patent CN109081861A offers high-purity 16a-hydroxy prednisonlone via solid base catalysis. Reduces cost and impurities for reliable pharmaceutical intermediate supply chains.
Patent CN114702430A reveals a novel route for N-substituted indoles. Discover cost-effective manufacturing and supply chain advantages for antibacterial drug intermediates.
Novel patent CN104774196A outlines high-purity benzimidazole derivative synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN1019395B reveals a streamlined alpha-alkylation method for mevinolin analogs, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Improved Belinostat synthesis method enhances safety and yield. Ideal for pharmaceutical intermediate manufacturing cost reduction and supply chain reliability.
Novel patent CN107501260B offers a scalable Venetoclax intermediate synthesis. Reduces costs by avoiding expensive precursors. Ideal for reliable pharmaceutical intermediate suppliers.
Patented 2-step synthesis of 4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzoic acid offers superior yield and safety for API supply chains.
Novel synthesis route for 3-bromo-2-methoxy-6-methylbenzoic acid ensures high purity and supply stability for SGLT2 inhibitor manufacturing.
Patent CN103103234A details immobilized enzyme technology for NAD production offering enhanced stability and conversion efficiency for supply chain optimization.
Patent CN108642119B details a lipase-catalyzed method for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.
Advanced synthesis of Lidocaine Hydrochloride Impurity E via patent CN111995539A. High purity, scalable process for reliable pharmaceutical intermediates supply chain optimization.
Novel preparation method for Ticagrelor Impurity VIII ensures 98% purity without chromatography. Reliable pharmaceutical intermediates supplier offering cost-effective scale-up solutions.
Patent CN112028727A details a robust Pd-catalyzed route for chiral indolines, offering high enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN115677521B enables high-yield Sacubitril Calcium Salt production. Reduced impurities and streamlined process offer significant supply chain and cost advantages for global buyers.
Advanced synthesis of chiral nitroxide radicals for radioprotection. Offers superior biocompatibility and scalable manufacturing for pharmaceutical intermediates.
Advanced melt crystallization patent CN118994097A ensures ≥99.5% purity for cephalosporin synthesis. Solvent-free process offers significant supply chain and cost advantages for global procurement.
Patent CN104447548B details a scalable route for HCV intermediates. This method offers high purity and cost efficiency for global supply chains.